Zimbabwe has rejected a major US healthcare agreement valued at 367 million US dollars (£272m) spanning five years due to the United States' insistence on sensitive information.
This rejection became public after a official document from December was leaked, indicating that Head of State Emmerson Mnangagwa felt the arrangement was "skewed".
An official representative has since clarified that the US was requesting health data for scientific study and commercial purposes but was unwilling to share the benefits from any future medical innovations.
"We must now begin the challenging and unfortunate task of scaling back our health aid in Zimbabwe," stated US ambassador to Zimbabwe Pamela Tremont in a statement.
Her embassy indicated the US had provided over $1.9bn in health funding to Zimbabwe during the past twenty years.
A physicians' group in Zimbabwe has urged more dialogue to reach a deal agreeable to both sides so the country's vital HIV programme can be sustained.
Wider Background
Zimbabwe's decision comes after a comparable case in Kenya, where a court suspended a similar deal with the US after legal challenges were raised about the security of citizens' health data.
Since resuming office last year, US President Donald Trump has drastically cut overseas assistance and shut down the US Agency for International Development (USAID).
USAID had managed aid for the American government, but Trump claimed its expenditure was "inefficient" and his administration was pursuing direct bilateral agreements to boost openness and accountability.
According to statements, Sixteen nations in Africa have to date signed these new health pacts, constituting more than $18.3bn in committed funds.
Specifics of the Rejected Agreement
The money for Zimbabwe was intended to supported "combating HIV/Aids, TB, malaria, healthcare for mothers and children, and disease outbreak preparedness.
"It is our view this cooperation could have provided significant benefits for the people of Zimbabwe, particularly the 1.2 million presently on HIV treatment through American-funded initiatives," Tremont added.
However, government spokesperson Nick Mangwana maintained the arrangement was "unequal".
"Zimbabwe was being asked to surrender its biological resources and data over an extended period, without any corresponding assurance of access to any medical innovations – such as vaccines, diagnostics, or treatments – that could result from that provided information," he stated.
"Put simply, our nation would provide the basic resources for scientific discovery without any certainty that the end products would be accessible to our people should a future disease outbreak arise."
National Interest and International Frameworks
He also pointed out that the American exit from the global health body and its push of one-on-one health agreements were undermining systems previously set up through the international organization.
Mangwana gave as an example its Pathogen Access and Benefit Sharing scheme designed to manage future pandemics.
"This system is intended to guarantee that when a country contributes its data, the benefits – such as vaccines and treatments – are distributed fairly, not commercialised solely by those with the funds to create them."
Zimbabwe's reservations over the US deal "are not meant as anti-American sentiment," Mangwana stressed.
"We encourage continued discussions with our American counterparts on how subsequent co-operation could be arranged in a manner that honours the independence and interests of each country."
Health Experts Reaction
The Zimbabwe College of Public Health Physicians (ZCPHP) stated it understood the government's concerns, but recommended that negotiations should continue since much of the nation's HIV programmes depended on foreign aid.
"In cases where specific concerns arise, including those relating to data governance or agreement terms, these can frequently be resolved via technical clarification and mutually agreed protections," it said.
The halted deal underscores the continuing debate between accepting vital foreign assistance and safeguarding national sovereignty in an ever more data-driven world.